Dg Capital Management, LLC Mannkind Corp Transaction History

Dg Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$2.67 - $4.77 $2.77 Million - $4.94 Million	-1,035,693 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$2.62 - $4.45 $1.37 Million - $2.33 Million	524,131 Added 102.46%	1,035,693 $3.81 Million
Q4 2021 Feb 14, 2022	BUY	$4.05 - $5.37 $301,218 - $399,393	74,375 Added 17.01%	511,562 $2.24 Million
Q2 2021 Aug 12, 2021	BUY	$3.61 - $5.45 $263,688 - $398,089	73,044 Added 20.06%	437,187 $2.38 Million
Q1 2021 May 13, 2021	BUY	$3.14 - $6.14 $1.14 Million - $2.24 Million	364,143 New	364,143 $1.43 Million

244

148M

1.62M

802K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.7B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of Dg Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Dg Capital Management, LLC with notifications on news.